BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)

NCT00887601 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia

Interventions

DRUG: MK3134
DRUG: Comparator: Placebo
DRUG: Donepezil
DRUG: MK3134

Sponsor

Merck Sharp & Dohme LLC